Skip to content

Evaluation of the effectiveness and safety of anal fistula plug for anal fistula repair

Evaluation of the effectiveness and safety of biomaterial anal fistula plug for anal fistula repair

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900023829
Enrollment
Unknown
Registered
2019-06-13
Start date
2016-03-30
Completion date
Unknown
Last updated
2019-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anal fistula

Interventions

Experimental group:anal fistula plug, produced by Beijing Biosis Healing Biological Technology Co.,Ltd
Control group:anal fistula plug, market product

Sponsors

Beijing Chaoyang Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) low anal fistula, and sinus (outer mouth) = 2 need to be repaired; (2) Aged 18 to 75 years old male and female; (3) Can follow the doctor's advice and return to the clinic regularly; (4) The subject agreed to participate in the clinical trial and signed an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients with = 3 sacral (external); (2) Patients with malignant diseases; (3) accompanied by cancer, intestinal tuberculosis, Crohn's disease, etc.; (4) Infection surgery or severely contaminated surgery; (5) Patients with severe cardiopulmonary disease; (6) Those with chronic kidney disease and renal insufficiency; (7) have a clear liver disease, liver dysfunction; (8) Specific allergic constitution, especially those sensitive to collagen or porcine-derived materials; (9) Those who have a history of allergies to a variety of drugs or who have recently had allergic diseases; (10) Pregnancy, lactation, and pregnancy planning; (11) Those who have participated in other clinical research within three months; (12) Patients with mental illness; (13) Subjects considered by the investigator to be unsuitable for participation in this clinical trial.

Design outcomes

Primary

MeasureTime frame
Healing rate;

Secondary

MeasureTime frame
Recurrence rate;Anal incontinence rate;Healing time;pain;Doctor satisfaction;Patient satisfaction;Convenient evaluation of anal congestion;

Countries

China

Contacts

Public ContactDavid

Beijing Chaoyang Hospital

zhengyidavid@163.com+86 010 85231604

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026